aiqbench takeMachine Learning
aiqbench analysis
Google DeepMind's release of AlphaGenome 2 advances machine learning applications in genomics by enabling cell-type-specific predictions of regulatory activity and variant effects. This tool provides researchers with a conditional DNA sequence model accessible via API for non-commercial analysis, marking a significant step toward precision medicine through AI-driven biological modeling.
2
Sources coveringMarkTechPost, SiliconANGLE
Google DeepMind Releases AlphaGenome 2 for Cell-Type-Specific Variant Effects
MarkTechPost1 min read
From MarkTechPost
SummaryGoogle DeepMind released AlphaGenome 2, a conditional DNA sequence model that predicts regulatory activity and variant effects per cell type. It is available via the AlphaGenome API for non-commercial research.